Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Seliger

Showing results (91-100 of 304) with videos related to

Pageof 31
Sort By:
Current Opinion in Immunology|March 12, 2016
Disentangling the relationship between tumor genetic programs and immune responsivenessDavide Bedognetti, Wouter Hendrickx, Michele Ceccarelli, et al.
International Journal of Molecular Sciences|August 28, 2020
Current Understanding of the HIF-1-Dependent Metabolism in Oral Squamous Cell CarcinomaAlexander W Eckert, Matthias Kappler, Ivo Große, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|March 26, 2025
Not Only Caseload but Also Patient Selection Is Predictive of Mortality After Pancreatic ResectionRene Mantke, Barbara Seliger, Shuji Ogino, et al.
Frontiers in Immunology|February 14, 2022
Transcriptional Analysis of Total CD8<sup>+</sup> T Cells and CD8<sup>+</sup>CD45RA<sup>-</sup> Memory T Cells From Young and Old Healthy Blood DonorsGeorgiana Toma, Ioana Maria Lemnian, Eliza Karapetian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2011
B7-h4 expression in human melanoma: its association with patients' survival and antitumor immune responseDagmar Quandt, Eckhard Fiedler, Diana Boettcher, et al.
Journal for Immunotherapy of Cancer|June 24, 2020
Targeting the coding sequence: opposing roles in regulating classical and non-classical MHC class I molecules by miR-16 and miR-744Michael Friedrich, Christoforos K Vaxevanis, Katharina Biehl, et al.
Frontiers in Medicine|September 26, 2022
<i>In vitro</i> models as tools for screening treatment options of head and neck cancerBarbara Seliger, Ahmed Al-Samadi, Bo Yang, et al.
Journal of Translational Medicine|October 28, 2009
Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinomaBarbara Seliger, Diana Handke, Elisabeth Schabel, et al.
Cancer Research|May 23, 2002
Increased tumorigenicity, but unchanged immunogenicity, of transporter for antigen presentation 1-deficient tumorsZhihai Qin, Christina Harders, Xuetao Cao, et al.
International Journal of Oncology|September 10, 2003
Analysis of the structural integrity of the TAP2 gene in renal cell carcinomaIsabelle Hodson, Michaela Bock, Ulrike Ritz, et al.
Pageof 31

Showing results (91-100 of 304) with videos related to

Sort By:
Pageof 31
Current Opinion in Immunology|March 12, 2016
Disentangling the relationship between tumor genetic programs and immune responsivenessDavide Bedognetti, Wouter Hendrickx, Michele Ceccarelli, et al.
International Journal of Molecular Sciences|August 28, 2020
Current Understanding of the HIF-1-Dependent Metabolism in Oral Squamous Cell CarcinomaAlexander W Eckert, Matthias Kappler, Ivo Große, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|March 26, 2025
Not Only Caseload but Also Patient Selection Is Predictive of Mortality After Pancreatic ResectionRene Mantke, Barbara Seliger, Shuji Ogino, et al.
Frontiers in Immunology|February 14, 2022
Transcriptional Analysis of Total CD8<sup>+</sup> T Cells and CD8<sup>+</sup>CD45RA<sup>-</sup> Memory T Cells From Young and Old Healthy Blood DonorsGeorgiana Toma, Ioana Maria Lemnian, Eliza Karapetian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2011
B7-h4 expression in human melanoma: its association with patients' survival and antitumor immune responseDagmar Quandt, Eckhard Fiedler, Diana Boettcher, et al.
Journal for Immunotherapy of Cancer|June 24, 2020
Targeting the coding sequence: opposing roles in regulating classical and non-classical MHC class I molecules by miR-16 and miR-744Michael Friedrich, Christoforos K Vaxevanis, Katharina Biehl, et al.
Frontiers in Medicine|September 26, 2022
<i>In vitro</i> models as tools for screening treatment options of head and neck cancerBarbara Seliger, Ahmed Al-Samadi, Bo Yang, et al.
Journal of Translational Medicine|October 28, 2009
Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinomaBarbara Seliger, Diana Handke, Elisabeth Schabel, et al.
Cancer Research|May 23, 2002
Increased tumorigenicity, but unchanged immunogenicity, of transporter for antigen presentation 1-deficient tumorsZhihai Qin, Christina Harders, Xuetao Cao, et al.
International Journal of Oncology|September 10, 2003
Analysis of the structural integrity of the TAP2 gene in renal cell carcinomaIsabelle Hodson, Michaela Bock, Ulrike Ritz, et al.
Pageof 31